New pyrrolopyrimidin-6-yl benzenesulfonamides:: Potent A2B adenosine receptor antagonists

被引:18
作者
Esteve, Cristina
Nueda, Arsenio
Diaz, Jose Luis
Beleta, Jorge
Cardenas, Alvaro
Lozoya, Estrella
Cadavid, Maria Isabel
Loza, Maria Isabel
Ryder, Hamish
Vidal, Bernat
机构
[1] Almirall, Dept Med Chem, E-08960 Barcelona, Spain
[2] Almirall, Dept Biol, E-08980 Barcelona, Spain
[3] Almirall, Dept Biol Struct, E-08980 Barcelona, Spain
[4] Univ Santiago de Compostela, Dept Farmacol, E-15782 Santiago De Compostela, Spain
关键词
A(2B) adenosine receptor antagonists; asthma; pyrrolopyrimidine; sulfonamides;
D O I
10.1016/j.bmcl.2006.04.074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 4-(1,3-dialkyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)benzenesulfonamides has been identified as potent AZB adenosine receptor antagonists. The products have been evaluated for their binding affinities for the human A(2B), A(1) and A(3) adenosine receptors. 6-(4-{[4-(4-Bromobenzyl)piperazin-1-yl]sulfonyl}phenyl)-1,3-dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione (16) showed a high affinity for the AZB adenosine receptor (IC50 = 1 nM) and selectivity (A(1): 183x; A(30): 12660x). Synthesis and SAR of this novel class of compounds showing improved absorption properties is presented herein. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3642 / 3645
页数:4
相关论文
共 18 条
  • [1] Theophylline - New perspectives for an old drug
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 813 - 818
  • [2] Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway
    Blackburn, MR
    Lee, CG
    Young, HWJ
    Zhu, Z
    Chunn, JL
    Kang, MJ
    Banerjee, SK
    Elias, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) : 332 - 344
  • [3] Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor
    Carotti, A
    Cadavid, MI
    Centeno, NB
    Esteve, C
    Loza, MI
    Martinez, A
    Nieto, R
    Raviña, E
    Sanz, F
    Segarra, V
    Sotelo, E
    Stefanachi, A
    Vidal, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 282 - 299
  • [4] AGONIST ACTIVITY OF 2-SUBSTITUTED AND 5'-SUBSTITUTED ADENOSINE-ANALOGS AND THEIR N6-CYCLOALKYL DERIVATIVES AT ADENOSINE-A1 AND ADENOSINE-A2 RECEPTORS COUPLED TO ADENYLATE-CYCLASE
    DALY, JW
    PADGETT, WL
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (05) : 1089 - 1093
  • [5] ADENOSINE IN BRONCHOALVEOLAR LAVAGE FLUID IN ASTHMA
    DRIVER, AG
    KUKOLY, CA
    ALI, S
    MUSTAFA, SJ
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (01): : 91 - 97
  • [6] Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists
    Elzein, E
    Rao, KA
    Li, XF
    Perry, T
    Parkhill, E
    Palle, V
    Varkhedkar, V
    Gimbel, A
    Zeng, DW
    Lustig, D
    Leung, K
    Zablocki, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 302 - 306
  • [7] Immunological characterization of A2B adenosine receptors in human mast cells
    Feoktistov, I
    Goldstein, A
    Sheller, JR
    Schwartz, LB
    Biaggioni, I
    [J]. DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) : 461 - 471
  • [8] The case for a role for adenosine in asthma: almost convincing?
    Fozard, JR
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (03) : 264 - 269
  • [9] Adenosine:: an endogenous regulator of innate immunity
    Haskó, G
    Cronstein, BN
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 33 - 39
  • [10] MEADE CJ, 2001, BIOCHEM PHARMACOL, V64, P317